— Know what they know.
Not Investment Advice

MHTX OTC

Manhattan Scientifics, Inc.
1W: +0.0% 1M: -90.0% 3M: -50.0% YTD: -90.0% 1Y: -90.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 46 · $5593 mcap · 474M float · 0.0000% daily turnover · Short 78% of daily vol

Balance Sheet Trends

Total Assets
$316K -69.4% ▼
5Y CAGR: -34.7%
Total Liabilities
$2M -22.3% ▼
5Y CAGR: -5.5%
Shareholders Equity
-$2M -6.3% ▼
Cash & Investments
$67K -61.7% ▼
5Y CAGR: -5.1%
Total Debt
$60K -45.5% ▼
Net Debt
-$7K +89.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$261K$353K$232K$175K$67K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$261K$353K$232K$175K$67K
Net Receivables$300K$300K$300K$0$0
Inventory-$300K-$300K-$300K$0$0
Other Current Assets$300K$300K$300K$0$0
Total Current Assets$574K$665K$547K$189K$69K
Property, Plant & Equip.$4K$6K$4K$1K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$1M$6M$3M$839K$245K
Other Non-Current Assets$602K$302K$2K$2K$2K
Total Non-Current Assets$2M$6M$3M$842K$247K
Total Assets$2M$7M$3M$1M$316K
— Liabilities —
Accounts Payable$234K$159K$102K$119K$133K
Short-Term Debt$0$0$130K$110K$60K
Deferred Revenue$0$0$0$0$10K
Other Current Liabilities$1M$0$0$0$0
Total Current Liabilities$2M$1M$1M$2M$2M
Long-Term Debt$78K$104K$0$0$0
Other Non-Current Liab.$1M$1M$1M$1M$1M
Total Non-Current Liabilities$1M$1M$1M$1M$1M
Total Liabilities$3M$2M$2M$3M$2M
— Equity —
Common Stock$558K$559K$559K$559K$559K
Retained Earnings-$69M-$65M-$69M-$71M-$72M
Accumulated OCI-$1M-$1M-$1M-$1M-$559K
Total Stockholders Equity-$1M$5M$1M-$2M-$2M
Total Liabilities & Equity$2M$7M$3M$1M$316K
— Key Metrics —
Total Debt$78K$104K$130K$110K$60K
Net Debt-$183K-$249K-$102K-$65K-$7K
Total Investments$1M$6M$3M$839K$245K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms